Merck to Acquire Prometheus Biosciences for $10.8B : compare

Merck & Co. has agreed to acquire Prometheus Biosciences for about $10.8 billion, the companies said Sunday.

Related Keywords

United States , San Diego , California , Scott Glenn , Stephan Targan , Robertm Davis , Mark Mckenna , Janine Bilsborough , Michaelj Yee , Dermotp Mcgovern , Jim Laur , Health Science , European Medicines Agency , Pfizer , Mayo Collaborative Services , Sinai Medical Center , Us Supreme Court , Sinai Technology Transfer Office , Colitis Organisation , Merck Co , Arena Pharmaceuticals , Prometheus Biosciences , European Crohn , Cedars Sinai Medical Center , Takeda Pharmaceutical , Nimbus Therapeutics , Human Papillomavirus , Human Papillomavirus Quadrivalent , Technology Transfer Office , Prometheus Laboratories , Federal Circuit , Hart Scott Rodino Antitrust Improvements , Prometheus Bioscience ,